Early Phase Cancer Immunotherapy

Book Overview

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

• Format: Hardcover
• Language: English
• ISBN: 3319637568
• ISBN13: 9783319637563
• Release Date: November 2017
• Publisher: Springer
• Length: 331 Pages
• Weight: 1.45 lbs.
• Dimensions: 0.8" x 6.1" x 9.2"